Evidence map›Paper›PMID 41407393›Full record

Observational studyBMJ open respiratory research2025

Air pollution, inhaled therapy and COPD exacerbations in Yunlin, Taiwan: a 2016-2024 single-centre retrospective cohort with environmental and carbon-footprint analyses.

Chung-Yu Chen, Ling-Yu Huang, Bor-Wen Cheng

Abstract readObservational Study
In one paragraph

Observational study in BMJ open respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chung-Yu ChenDepartment of Internal Medicine, National Taiwan University Hospital Yun Lin Branch, Douliu, Taiwan c8101147@ms16.hinet.net.ORCID http://orcid.org/0000-0001-9002-7255
Ling-Yu HuangPublic Health Bureau, Yunlin, Douliou, Taiwan.
Bor-Wen ChengNational Yunlin University of Science and Technology, Douliu, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAir pollution exacerbates chronic obstructive pulmonary disease (COPD), increasing hospitalisation and exacerbation rates. While inhaled therapy is a cornerstone of COPD management, pressurised metered-dose inhalers (pMDIs) significantly contribute to greenhouse gas (GHG) emissions. This study evaluates the interplay between air pollution exposure, inhaled therapy selection and COPD exacerbations to identify strategies that optimise clinical outcomes while reducing environmental impact.

methodsA retrospective observational cohort study was conducted using COPD patient records (ICD-10: J44.0, J44.1, J44.8, J44.9) from the National Taiwan University Hospital Yunlin Branch (2016-2024). Patient visits, including outpatient, emergency and inpatient admissions, were analysed alongside air pollution data (PM

resultsHigher PM

conclusionIn this single-centre retrospective study, higher ambient PM

Indexed as

Air PollutionCarbon FootprintPulmonary Disease, Chronic ObstructiveAdministration, InhalationAdrenergic beta-2 Receptor AgonistsAgedDisease ProgressionFemaleHospitalizationHumansMaleMetered Dose InhalersMiddle AgedMuscarinic AntagonistsRetrospective StudiesTaiwanAdrenergic beta-2 Receptor AgonistsMuscarinic AntagonistsCOPD ExacerbationsInhaler devices

Identifiers

PMID41407393
PMCPMC12716513

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.